Barclays
http://www.barclays.com/Barclays plc is a global financial services provider engaged in retail and commercial banking, credit cards, investment banking, wealth management and investment management services. It has an extensive international presence in Europe, the United States, Africa and Asia. In addition, the bank is one of the ten largest banks in the world measured by market capitalization. Barclays is headquartered in London, England.
Notable Analyst Rating Changes 02/08: BYD, SNDK, MGM, RFMD Upgraded; BIG, ARMH, FSLR, GNW Downgraded
-
Notable Analyst Rating Changes 10/20: NIHD, MOS, JNPR, SYK Upgraded; AMLN, BAC, FSII, WDC Downgraded
-
Barclays Maintains an 'Overweight' Rating on Amylin Pharmaceuticals (AMLN); TRx Share Continues to Increase Byetta Losing Share in GLPs
-
Notable Analyst Rating Changes 06/28: DOW, AMLN, RIMM, FINL Upgraded; AMZN, LYG, SOL, BCS Downgraded
-
Notable Analyst Rating Changes 03/29: SWN, SVR, CBG, SOLF, SYUT Upgraded; SNV, DRC, TAP, PEET Downgraded
-
Notable Analyst Rating Changes 01/26: AMLN, PVTB, VLTR, AMAT, SPWRA, NVLS Upgraded; CI, WBD, JCI, GXDX Downgraded
-
Amlylin Pharma (AMLN): Upgraded to Buy at Citigroup; Street high target of $27
-
Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
-
Amylin Pharmaceuticals (AMLN): Upgraded to Overweight at Barclays, target raised to $22
-
Barclays Upgrades Amylin Pharmaceuticals (AMLN) to Overweight
-
Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
-
David Moenning's Daily State of the Markets: 1/28
-
Morning Movers 1/28: Bank Stock Up On "Bad Bank" Plan (BAC, C, JPM, WFC)
-
Notable Analyst Rating Changes 10/06: MON, DLTR, AMLN, JBL Upgraded; KO, CLS, RFMD, MT Downgraded
